Who are Cholecalciferol 100.000 UI administration's main competitors?

No direct comparators detected in our index.

How often does this brief refresh?

Every 30 minutes from primary sources (FDA, EMA, MHRA, PMDA, ClinicalTrials.gov, USPTO). Subscribe to the RSS feed below for push alerts.

How do I get this as a recurring report?

Subscribe to /feed/ci/cholecalciferol-100-000-ui-administration.xml in any RSS reader (Feedly, Inoreader, NewsBlur). Every regulatory action, trial readout, or patent event lands in your feed automatically.

Last reviewed 2026-05-16 · How we verify

Cholecalciferol 100.000 UI administration — Competitive Intelligence Brief

Cholecalciferol 100.000 UI administration (Cholecalciferol 100.000 UI administration) competitive landscape: 0 comparators, recent regulatory actions, upcoming PDUFA, patent timeline. Class: Vitamin D analog / Nutritional supplement. Area: Nephrology / Mineral metabolism / Immunology.

phase 3 Vitamin D analog / Nutritional supplement Vitamin D receptor (VDR) Nephrology / Mineral metabolism / Immunology Small molecule Live · refreshed every 30 min

Target snapshot

Cholecalciferol 100.000 UI administration (Cholecalciferol 100.000 UI administration) — Institut Phoceen de Nephrologie. Cholecalciferol (vitamin D3) is converted in the body to its active form, calcitriol, which regulates calcium and phosphate homeostasis and modulates immune function.

Comparator set

Auto-detected by same drug class / molecular target / therapeutic area, ranked by phase + recency. Override with ?vs=slug1,slug2,….

Drug	Generic	Sponsor	Phase	Class	Target	Approval / PDUFA
Cholecalciferol 100.000 UI administration TARGET	Cholecalciferol 100.000 UI administration	Institut Phoceen de Nephrologie	phase 3	Vitamin D analog / Nutritional supplement	Vitamin D receptor (VDR)

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this set.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this set.

Patent timeline (forward window)

No upcoming patent expiries for this set.

Sponsor landscape (Vitamin D analog / Nutritional supplement class)

Institut Phoceen de Nephrologie · 1 drug in this class

Subscribe to ongoing alerts

Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:

Cite this brief

Drug Landscape (2026). Cholecalciferol 100.000 UI administration — Competitive Intelligence Brief. https://druglandscape.com/ci/cholecalciferol-100-000-ui-administration. Accessed 2026-05-16.

Build your own brief

Pick any drug + add comparators:

https://druglandscape.com/ci/{slug} — auto-detected competitors
https://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3 — explicit comparators
Brand names auto-resolve: /ci/keytruda → 301 → /ci/pembrolizumab